Your browser doesn't support javascript.
loading
Effects of percutaneous angioplasty on kidney function and blood pressure in patients with atherosclerotic renal artery stenosis
Kidney Research and Clinical Practice ; : 336-346, 2019.
Article Dans Anglais | WPRIM | ID: wpr-759007
ABSTRACT

BACKGROUND:

Previous randomized controlled trials of revascularization for atherosclerotic renal artery stenosis (ARAS) were not successful. We investigated the effects of percutaneous transluminal angioplasty with stent insertion (PTA/S) on kidney function and blood pressure (BP) control in patients with ARAS.

METHODS:

From 2000 to 2017, 47 subjects who underwent PTA/S for ARAS were identified. A high-risk group was defined, composed of patients having one or more of the following clinical presentations pulmonary edema, refractory hypertension, and rapid deterioration of kidney function. Subjects who met the criteria of ‘kidney function improvement’ or ‘hypertension improvement’ after PTA/S were classified as responders.

RESULTS:

Twenty-one (44.7%) subjects were classified into the high-risk group. Two subjects (8.0%) in the low-risk group (n = 25) and 5 subjects (27.8%) in the high-risk group (n = 18) showed improvement in kidney function after PTA/S (P = 0.110). In patients with rapid decline of kidney function, estimated glomerular filtration rate improved from 28 (interquartile range [IQR], 10–45) mL/min/1.73 m² to 41 (IQR, 16–67) mL/min/1.73 m² at 4 months after PTA/S, although the difference was not significant (P = 0.084). Regarding BP control, 9 (36.0%) and 14 (77.8%) subjects showed improvement after PTA/S in the low- (n = 25) and high-risk (n = 18) groups, respectively (P = 0.007). In patients with refractory hypertension, the systolic BP dropped from 157 (IQR, 150–164) mmHg to 140 (IQR, 131–148) mmHg at 4 months after PTA/S (P = 0.005). Twenty-five subjects were defined as responders and comprised a significant proportion of the high-risk group (P = 0.004).

CONCLUSION:

PTA/S might improve BP control and kidney function in patients with ARAS presenting with high-risk clinical features. The optimal application of PTA/S should be based on individual assessment of the clinical significance of renal artery stenosis.
Sujets)

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Oedème pulmonaire / Artère rénale / Occlusion artérielle rénale / Pression sanguine / Endoprothèses / Angioplastie / Débit de filtration glomérulaire / Hypertension artérielle / Rein Type d'étude: Essai clinique contrôlé / Étude pronostique Limites du sujet: Humains langue: Anglais Texte intégral: Kidney Research and Clinical Practice Année: 2019 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Oedème pulmonaire / Artère rénale / Occlusion artérielle rénale / Pression sanguine / Endoprothèses / Angioplastie / Débit de filtration glomérulaire / Hypertension artérielle / Rein Type d'étude: Essai clinique contrôlé / Étude pronostique Limites du sujet: Humains langue: Anglais Texte intégral: Kidney Research and Clinical Practice Année: 2019 Type: Article